Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations ...

Chicago-based biotech Cour Pharmaceuticals announced the hiring of former Acelyrin executive Paul M. Peloso, MD as chief ...

The global biopharmaceuticals market is poised for significant growth, with its value expected to reach USD 566 billion by ...

Dr. Peloso to lead COUR’s clinical development programs as the company advances towards late-stage developmentCHICAGO, May 21, 2024 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage ...

The Specialty Pharmaceutical Market is experiencing significant growth, driven by several key factors. The market is projected to grow from USD 68.3 billion in 2023 to USD 1532.8 billion by 2033, ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the ...

A new study found that spending on prescription drugs in the U.S. has skyrocketed in the last year. These are the top 25 ...